The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomesVin‐Cent Wu, Kwan‐Dun Wu|Scientific Reports|2017Cited by 93
GLP-1 receptor agonists’ impact on cardio-renal outcomes and mortality in T2D with acute kidney diseaseHeng‐Chih Pan, Vin‐Cent Wu|Nature Communications|2024Cited by 65
Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohortJun Yang, Mitsuhide Naruse, Yoshikiyo Ono et al.|The Lancet Diabetes & Endocrinology|2025Cited by 53
Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysisJui‐Yi Chen, Vin‐Cent Wu, Heng‐Chih Pan et al.|Cardiovascular Diabetology|2023Cited by 39
Acute kidney injury in patients with COVID-19 compared to those with influenza: a systematic review and meta-analysisChiu-Ying Hsiao, Jui‐Yi Chen, Heng‐Chih Pan et al.|Frontiers in Medicine|2023Cited by 5